The SETD1B (SET Domain Containing 1B) gene encodes a histone H3 lysine 4 (H3K4) methyltransferase, a critical epigenetic enzyme involved in transcriptional regulation and chromatin remodeling. SETD1B is a component of the SET1/COMPASS complex, which catalyzes H3K4 methylation, a histone modification associated with active gene transcription.
SETD1B is a large protein (~1,700 amino acids) with several functional domains:
The SET1/COMPASS complex consists of multiple subunits that work together to catalyze H3K4 methylation at specific genomic loci[2].
SETD1B-mediated H3K4 methylation is essential for:
During neurogenesis, SETD1B regulates genes critical for:
H3K4 methylation is dynamically regulated in the hippocampus during learning and memory formation. SETD1B activity is required for:
SETD1B dysregulation has been implicated in Alzheimer's disease (AD) pathogenesis:
In dopaminergic neurons, SETD1B regulates genes involved in:
Alterations in SETD1B activity may contribute to dopaminergic neuron vulnerability in PD[7].
SETD1B and other H3K4 methyltransferases are affected in ALS:
De novo mutations in SETD1B cause intellectual disability, developmental delay, and autistic features[9]. These findings highlight SETD1B's critical role in human neurodevelopment.
SETD1B is widely expressed in the brain:
Targeting SETD1B and H3K4 methylation offers therapeutic potential:
Shilatifard A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu Rev Biochem. 2012. ↩︎
Wu M, et al. Molecular regulation of H3K4 trimethylation by WDR82-mediated recruitment of the SET1/COMPASS complex. Mol Cell. 2008. ↩︎
Chen K, et al. Histone H3K4 methyltransferase SET1 is required for neuronal morphogenesis and cortical development. Cell Rep. 2019. ↩︎
Jakovcevski M, Akbarian S. Epigenetic mechanisms in neurological disease. Nat Med. 2012. ↩︎ ↩︎
Gupta S, et al. Histone methylation regulates memory formation. Neuron. 2010. ↩︎
Liu X, et al. Dysregulation of histone H3K4 methylation in Alzheimer's disease. J Neurosci. 2021. ↩︎ ↩︎ ↩︎ ↩︎
Zhang J, et al. SETD1B regulates mitochondrial function in dopaminergic neurons. Mol Neurodegener. 2020. ↩︎ ↩︎
Chestnut BA, et al. Epigenetic regulation of motor neuron degeneration. Neurobiol Dis. 2021. ↩︎ ↩︎
Kuechler A, et al. Mutations in SETD1B cause intellectual disability and underlie a broader neurodevelopmental phenotype. Am J Hum Genet. 2018. ↩︎ ↩︎ ↩︎
Kelly TK, et al. Epigenetic modifications as therapeutic targets. Nat Biotechnol. 2010. ↩︎